The evolutionary cost of gene loss is a central question in genetics and has been investigated in model organisms and human cell lines [1] [2] [3] . In humans, tolerance of the loss of one or both functional copies of a gene is related to the gene's causal role in disease. However, estimates of the selection and dominance coefficients in humans have been elusive. Here we analyze exome sequence data from 60,706 individuals 4 to make genome-wide estimates of selection against heterozygous loss of gene function. Using this distribution of selection coefficients for heterozygous protein-truncating variants (PTVs), we provide corresponding Bayesian estimates for individual genes. We find that genes under the strongest selection are enriched in embryonic lethal mouse knockouts, Mendelian disease-associated genes, and regulators of transcription. Screening by essentiality, we find a large set of genes under strong selection that are likely to have crucial functions but have not yet been thoroughly characterized.
The dispensability of individual genes for viability has interested generations of geneticists. Approaches used in nonhuman sexual organisms to estimate selection and dominance coefficients are not applicable to humans, as they generally require cross-breeding over several generations. This has precluded reliable estimates of these crucial parameters in humans to date. The analysis of patterns of natural genetic variation in humans provides an alternative approach to estimating selection intensity and dispensability of individual genes.
Despite substantial methodological progress in the ascertainment and analysis of population sequence data [5] [6] [7] [8] [9] , estimation of parameters of natural selection in humans has been complicated by genetic drift, complexities of human demographic history 5, 6, 8, [10] [11] [12] [13] , and the role of nonadditive genetic variation [14] [15] [16] . Additionally, naturally occurring PTVs are infrequent in the population, so data sets of thousands of individuals are underpowered for the estimation of gene dispensability in humans.
The Exome Aggregation Consortium (ExAC) data set now provides a sample sufficiently powered to directly estimate the selection that constrains the number of gene-specific PTVs in the general population 4 . We restricted our analysis to PTVs predicted to be consequential 17 , which allows the assumption that all PTVs within a gene probably incur the same selective disadvantage. We can then treat each gene as a biallelic locus with a functional state and a loss-of-function state.
In each gene, the cumulative frequency of rare deleterious PTVs (the sum of PTV allele frequencies throughout the gene) is then primarily determined by the balance between incoming mutations and selection rather than reassortment of alleles by stochastic drift. This makes our estimates robust to drift, population structure, and historical changes in population size, which we evaluate analytically and with simulations (Online Methods and Supplementary Fig. 1 ).
Using population frequency data from 60,706 individuals without severe Mendelian disorders, we estimated both the overall distribution of gene-based fitness effects and individual gene fitness cost in heterozygotes. Given gene-specific estimates of the de novo mutation rate 18, 19 , the observed number of PTV alleles throughout each gene, and number of chromosomes sampled, we estimated the genomewide distribution of selective effects for heterozygous PTVs (s het ). We parameterized the distribution of selective effects using an inverse Gaussian, which is fit using maximum likelihood (Fig. 1) . We then estimated individual gene selection coefficients using the posterior probability for s het given gene-specific values of the observed number of PTVs, number of chromosomes sampled, and estimated mutation rate (Supplementary Table 1) .
Although the distribution is broad, suggesting that the effect of losing one copy of a gene is variable, the mode of the distribution corresponds to a fitness loss of ~0.5% (s het = 0.005). Despite the large sample size, resolution to distinguish between very high selective effects is limited. There are 2,984 genes with s het > 0.1, a result concordant with previous estimates of loss-of-function intolerance derived from population data 4 . Even though some genes are heavily depleted of PTVs in ExAC as compared with mutational expectation, these values suggest that heterozygote PTVs in many genes are not necessarily responsible for observable, severe clinical consequences.
Unsurprisingly, however, Mendelian disease genes had higher s het values. Among them, genes annotated exclusively as autosomal dominant (AD, N = 867) had significantly higher s het values than those annotated as autosomal recessive 20 (AR, N = 1,482) (P = 3.14 × 10 −64 , Mann-Whitney) (Fig. 2a,b) . This suggests that it may be possible to prioritize candidate disease-associated genes identified in clinical exome-sequencing analysis using the observed mode of inheritance and s het value.
In 504 clinical exome cases that resulted in Mendelian diagnosis 21 , we found a similar enrichment of cases by mode of inheritance and selection value (Fig. 2c) . We found that 90.4% of novel, dominant variants were associated with heterozygous fitness loss >0.04 (Fig. 2d) . Among disease variants, a cutoff of s het > 0.04 provided a 96% positive predictive value for discriminating between AD and AR.
To test the generalizable utility of prioritizing candidate genes in Mendelian sequencing studies using s het , we compared the overall prevalence of genes with s het > 0.04 to the corresponding fraction in an independently ascertained data set of new dominant Mendelian diagnoses 22 (Fig. 2e) . The results suggest that restricting to genes with s het > 0.04 would provide a threefold reduction of candidate variants, given the overall distribution of s het values. Thus, initial effort in clinical cases can be focused on just a few genes for functional validation, familial segregation studies, and patient matching. We summarize the classification accuracy (area under the curve (AUC) 0.931) and generate mode of inheritance probabilities for each gene using the full set of clinical sequencing cases ( Supplementary Fig. 2 and Supplementary Table 2) .
Beyond mode of inheritance, we found that s het helps predict phenotypic severity, age of onset, penetrance, and the fraction of de novo variants in a set of high-confidence haploinsufficient disease-associated genes (Fig. 3) . In broader sets of known disease-associated genes, s het estimates correlated significantly with the number of references in OMIM MorbidMap and the number of HGMD disease 'DM' variants ( Supplementary Fig. 3 ).
Gene-specific fitness loss values allow us to plot the distribution of selective effects for different disorders. This provides information about the breadth and severity of selection associated with various disorder groups using both well-established genes (Fig. 4a) and findings from Mendelian exome cases (Fig. 4b) . Overall, genes involved in neurologic phenotypes and congenital heart disease appeared to be under more intense selection than other disorder groups or tolerated knockouts from a consanguineous cohort 23 (Fig. 4c,d) . Notably, genes recessive for these disorders appeared to have only partially recessive effects on fitness, so selection on heterozygotes is not negligible in these genes (Fig. 4) .
In germline cancer predisposition, genes under stronger selection are enriched in individuals with cancer over those in ExAC (Supplementary Fig. 4 ). This suggests that genes with low s het values should not be prioritized in prospective genetic screening for cancer predisposition. Consistent with previous studies 18 , we found that de novo mutations in patients with autism spectrum disorder were significantly enriched in genes under stronger selection than those identified in controls ( Supplementary Fig. 5 and Supplementary Table 3) .
Next, we analyzed s het in the context of developmental and functional assays. In a large set of neutrally ascertained mouse knockouts 24 (N = 2,179), mice that were null mutant for orthologous genes with higher s het estimates were enriched for embryonic lethality or subviability, whereas those with the lowest s het estimates were depleted for embryonic lethality (Mann-Whitney P = 2.95 × 10 −28 ) (Fig. 5a,b) .
It is well known that mutations that are haploinsufficient in humans can often be well-tolerated when heterozygous in mice 25 . 
l e t t e r s l e t t e r s
A classic example is SHH; heterozygous null mutations in this important developmental signaling gene result in holoprosencephaly 26 .
Haploinsufficiency for other genes in this signaling pathway also results in developmental defects, as with GLI3 (Pallister-Hall syndrome and Greig cephalopolysyndactyly syndrome) [27] [28] [29] and GLI2 (holoprosencephaly 9) 30 . Interestingly, haploinsufficiency for these genes is tolerated in mouse models; mice heterozygous for null variation in the Shh signaling pathway are phenotypically normal, whereas homozygous mutant mice have defects that recapitulate features of the human syndrome [31] [32] [33] . This extends to many other human developmental disorders, enabling the experimental characterization of the molecular consequences of these mutations. Thus, it is notable that homozygous null mice in orthologous genes with higher s het values are enriched for lethality. High-throughput genetic analysis of cell essentiality provides an orthogonal data set for comparison with s het . In genes putatively essential for human cell proliferation using CRISPR-based inactivation ( Fig. 5c ) and gene trap inactivation assays 3 (Fig. 5d) , essential genes were heavily enriched with high s het values (P = 5.13 × 10 −16 and 4.90 × 10 −18 , respectively).
Key developmental pathways were highly enriched in genes under strong selection (Fig. 6a) . We also found a significant positive correlation between the number of protein-protein interactions for each gene and its s het value (Fig. 6b,c) , identified from high-throughput mass spectrometry data Mann-Whitney U-test P = 6.67 × 10 −9 . In the context of molecular and cellular function, a set of genes with very high selective effects (s het > 0.15; 2,072 genes) were enriched in biological process categories 'transcription regulation' (Benjamini P = 2.99 × 10 −37 ), 'transcription' Benjamini association P = 9.73 × 10 −36 , and 'negative regulators of biosynthetic processes' 34 (Supplementary Table 6 ). The nucleus was the most enriched cellular compartment for these genes (Benjamini-corrected association P = 4.8 × 10 −76 ). The enrichment of transcription factors in these genes is consistent with literature that describes dosage dependence for enzymatic proteins and haploinsufficiency for transcriptional regulators 35 .
Selection estimates from human PTVs provide a measure of gene dispensability that is unbiased with respect to existing knowledge. Thus, these estimates may highlight genes that have a key role in development or in maintaining core cellular functions. Many genes with high fitness costs have not previously been described in human genetics studies. Given the marked enrichment of genes with high s het values associated with Mendelian disorders, cell essentiality, embryonic lethality, and development, it is plausible that many genes with high s het values have not been previously associated with human disease because they are required for embryonic development.
We inspected genes with high s het values but for which there are few disease annotations or publications to determine whether they have functional and genetic features reminiscent of known genes with central roles in cell housekeeping and developmental biology. We measured the relative l e t t e r s knowledge about each gene in the primary literature from Entrez and PubMed 36 using the number of gene reports connected with each manuscript, and summed the weighted contributions across all available manuscripts 37 (PubMed score, Online Methods). Although the PubMed score was positively correlated with s het values, a substantial number of understudied genes fell in the highest s het decile (Supplementary Fig. 6 ).
We selected the 250 most cited and least cited genes within the top s het decile and compared their frequency of protein-protein interactions, viability of orthologous mouse knockouts, and cell essentiality assays. Genes with the fewest publications (no more than one citation) had nearly the same number of embryonic lethal mouse knockouts as genes with the most publications. Other assay results were only slightly depleted in genes with the fewest publications (Supplementary Fig. 7) . These findings suggest there may be essential developmental pathways yet to be uncovered in genes under strong selection that lack functional or disease annotations and provides a promising gene set for further exploration. We have created a prioritized list of genes developed from functional evidence to indicate the most promising candidates for future functional screening (Supplementary Table 4) .
To place our inferences in the broader evolutionary context, we used comparable estimates from model organisms, including flies and yeast, based on knockout competition with wild type or explicit crosses. In yeast, analysis of a library of PTV knockouts provided a mean estimate of s het ≈ 0.013, which is close to our inferred results (s het ≈ 0.059) in humans 38 , given that the functional experiments excluded genes with very high s and we have excluded genes with high cumulative allele frequency. Estimates in flies derived from homozygous lethal mutations that reduce viability in heterozygotes (rather than only PTVs) suggested values of s het on the order of 1-3%, which is also in broad agreement with our estimates in humans 1, 39 (Supplementary Note). Although values of s in this range have a small impact in each generation, they may have dramatic evolutionary consequences 40 .
Here we used the genome-wide distribution of PTVs to estimate fitness loss due to heterozygous loss of each gene. Unlike recent work on genic intolerance 18, 41 , our study explicitly estimates the distribution of selection coefficients for PTVs on genes with X < 0.001. Our estimates are also distinct from earlier work on the estimation of fitness effects of allelic variants in humans 42 , as the large sample size coupled with the assumption of strong selection makes our approach robust with respect to complexities of demographic history and dominance and allows genebased inferences. Conversely, our assumptions are justified for many but not all genes, as the method has limited resolution for genes under the strongest or weakest selection. These results may be useful in Mendelian disease gene-discovery efforts and provide clinical utility in the inference of severity and mode of inheritance underlying Mendelian disease.
URLs. LOFTEE, https://github.com/konradjk/loftee.
MeTHodS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
COMPEtING FINANCIAL INtEREStSoNLINe MeTHodS
Model of deterministic mutation-selection balance. For most genes, protein-truncating alleles are both individually and collectively rare. For genes in which they are collectively rare, estimation of the selective effect against heterozygous PTVs (s het ) can be greatly simplified. We model each gene as a single biallelic locus with cumulative frequency
where the sum is over PTV sites j. This is motivated by the simplifying assumption of identical selection coefficients for all PTVs within a gene and the observation that the frequency of the vast majority of PTVs is extremely low such that the occurrence of multiple variable sites within a gene on a single haplotype is also extremely low (2Nx j x k < 1 for sample size N). Moreover, multiple PTVs in a gene in an individual would be functionally equivalent to a single PTV resulting in a loss-of-function state. Then, for each gene, the cumulative allele frequency X is influenced by incoming mutation, selection and the random reassortment of alleles (genetic drift). When selection is strong, s >> 2.5 × 10 −5 (i.e., when 4N e s >> 1, with effective population size N e = 10 4 ), drift is much smaller than the contribution of selection. Furthermore, the strength of genetic drift is weakest for genes at low frequencies: for a variant with cumulative frequency of X = 0.001 the expected frequency change due to drift is only 〈∆X 2 〉 ~ X/4N e = 2.5 × 10 −8 per generation. Notably, at the locus level, assuming X << 1, the drift contribution is also much smaller than the mutational influx. Hence, under strong selection and for small allele frequencies, the expected cumulative frequency of PTVs is determined by the equilibrium between the influx of de novo mutations (estimated to increase the cumulative frequency by an average 1.4 × 10 −6 per locus per generation by mutational model) and the outflux due to natural selection.
In the presence of selection on both heterozygotes and homozygotes and ignoring back mutations, the dynamics of X are captured by
Here U represents the PTV mutation rate at the gene locus per individual per generation, and s het = hs > 0 and s hom = s > 0 represent the strength of negative selection against PTV heterozygotes and homozygotes, respectively. We note that compound heterozygotes (with a single PTV on each chromosome) are treated as homozygotes under the biallelic assumption. Provided X << 1 as is the case for PTVs under strong selection (2N e s >> 1), this equation simplifies dramatically:
Because X << 1, selection against heterozygotes (the linear term) generally also dominates over selection against homozygotes (the quadratic term), provided s het /s hom >>X. This is violated only in cases of extreme recessivity (where the dominance coefficient h << 0.001), but even in that case the expected cumulative frequency of PTVs in essential genes is unlikely to exceed 0.001 (the characteristic X in the completely recessive case is U s /~10 3 − when s ~ 1; see simulations in Supplementary Fig. 1 ). The strong selection regime thus corresponds to mutation-selection balance in the heterozygote state of a PTV mutation. In our model, we do not assume that selection acts exclusively on heterozygotes but aim at estimating only fitness loss due to the lack of one functional copy of a gene. Even in the case of strong selection against homozygotes, the population frequency is primarily controlled by efficient selection against heterozygotes. Notably, there is no dependence on demography or population size in this regime, as the contribution from drift vanishes because selection drives alleles out of the population efficiently and on very short time scales. Classic papers by Li 43, 44 and Maruyama 45, 46 showed that relevant time scales are short, even in the case of exponential expansion, because individual deleterious alleles are predominantly recent, with an allelic age on the order of 1/s. Current estimates of recent population histories for most of populations included in the ExAC data set suggest that 4Ns safely exceeds 1. Even if individual alleles are subject to stochastic drift, this effect is mitigated by the aggregation of variants on the (1) (1) (2) (2) gene level. One possible concern is the inclusion of individuals with Finnish ancestry, as this population underwent an intense, relatively recent bottleneck. We address this population explicitly using forward simulations and by removing them from our analysis to show no significant deviation from our initial estimates in their absence (below).
From equation (2) follows that for a population sample of size N chromosomes, sample allele counts n NX N x j j = = ∑â re expected to be Poisson distributed around the expectation given by:
Generally, genes under the strongest and weakest selection are expected to have greater estimation uncertainty, as the resolution to estimate s het deteriorates when variants are so common that they may be controlled not only by heterozygote selection but also by drift or complex demography. However, the overwhelming majority of genes conform to our assumptions of cumulative PTV allele frequency not exceeding 0.001. Despite issues such as the admixture of populations, consanguineous samples in ExAC 23 , and the Wahlund effect, very few genes (1,201 of 17,199 covered genes) have higher estimated cumulative allele frequencies X , which we restrict from the estimation procedure. On the other end of the spectrum, genes under strong selection may lack PTVs by chance alone in ExAC, which limits the ability to distinguish between large selective effects.
Population genetics simulations of model assumptions.
To validate the assumption that estimates of selection can be made under mutation-selection balance independently of demography or population size for variants under sufficiently strong selection, we used SLiM 2.0 to conduct forward population genetics simulations 47 . We ran 10,000 replicates each of simulations with selection coefficients of −5 × 10 −2 , −5 × 10 −3 , −5 × 10 −4 , −5 × 10 −5 , and −5 × 10 −6 through a realistic demography derived from previously published histories for African, non-Finnish European, and Finnish populations 48, 49 (Supplementary Fig. 1) . We compare the theoretical expectation of cumulative allele frequency (U/s het (equation (3)) with the simulated cumulative allele frequency. We do this in three populations (African, non-Finnish European, and Finnish), plus a 'combined' population that includes pooled site frequency spectra from all three populations in proportions represented in the ExAC data set. The simulations support our assumption of mutation-selection balance in the strong selection regime (|s het | ≥ 1 × 10 −3 ), which appears to be appropriate for PTVs. This is true for all three populations examined and for the combined population, demonstrating that this assumption is robust to differences in the strength of drift due the distinct demographic histories of included human populations.
All simulations had a length of 100 bp, mutation rate of 2 × 10 −8 per generation per base pair, and recombination rate of 1 × 10 −5 per generation per base pair. The high recombination rate was chosen to simulate largely unlinked sites, as we are simulating PTVs that are infrequent enough that they are expected not to be in linkage with other PTVs in the same gene. Data set for s het estimation. In this analysis, we used ExAC data set version 0.3, a set of jointly called exomes from 60,706 individuals ascertained with no known severe, early-onset Mendelian disorders. The mean coverage depth was calculated for each gene (canonical transcript from Ensembl v75, GENCODE v19) in the ExAC data set (mean 57.75; s.d. 20.96). Genes with average coverage depth of at least 30× were used in further analysis (N = 17,199). Single nucleotide substitution variants annotated as PASS quality with predicted functional effects in the canonical transcript of 'stop_gained' , 'splice_donor' , or 'splice_acceptor' (as annotated by Variant Effect Predictor) were included in the analysis. Variants such as indels, in-frame mutations, and frameshift variants were excluded from this analysis, as many of these variants may have annotation issues or may not be functionally impactful. Along the same lines, we are mindful that not all PTVs will result in complete loss of gene function, due to alternative transcripts or nonsense mediated decay. To address this, variants were filtered using LOFTEE and restricted to those predicted with high confidence to have consequences in the canonical transcript. for (n, U, N) , where n denotes the total number of observed PTV alleles in the population sample of N chromosomes covered in the gene, and U the PTV mutation rate across the canonical gene transcript from a mutational model 18, 19 . Values of U for each gene from Samocha et al. 18 were used along with the number of well-covered chromosomes N in each gene to generate the null mutational expectation of neutral evolution, NU. Incorrectly specified values from this mutational model could alter estimates of selection for individual genes, as higher estimates of selection are made in genes with greater depletions from the null expectation model. Our inference of selection coefficients relies on the assumption that the cumulative population frequency of PTV mutations, X, is small owing to strong negative selection, so genes with ˆ/ . X n N = > 0 001 are omitted from the analysis, leaving 15,998 genes.
Estimation of P(s het ).
A genome-wide ensemble of observed (n) and expected (NU ≡ ν) genic PTV counts enables the inference of the distribution of heterozygous loss-of-function fitness effects, P(s het ), which underlies the evolutionary dynamics of this class of mutations. We estimate the parameters (α, β) of this distribution by fitting the observed distribution of PTV counts across genes:
For a given gene under negative selection, PTV mutations are rare events, such that we expect a Poisson distribution for the likelihood of the observed number of PTVs P n s n | = Pois het ;
; n l ( ) ( ) , where l n = / s het (equation (3)). We parameterize by using the functional form of an inverse Gaussian distribution, i.e., P s s In order to account for a slight positive correlation between the mutation rate and selection strength (Supplementary Fig. 8 ), we separately perform the fit on U terciles of the data set and combine the results in a mixture distribution with equal weights. The mean mutation rates in the three terciles are U 1 
The choice for the functional form of P(s het ) is motivated by the shape of the empirical distribution of the naive estimator ν/n (given by a simple inversion of equation (3). We also compared the log-likelihood of the fit to Q(n) obtained with this model to that obtained from two other two-parameter distributions,
s het ~ Gamma and s het ~ InvGamma, and chose the model with the highest likelihood, which is s het ~ IG.
To assess the relative change in the distribution of heterozygote selection coefficients when different population subsets are included, we first estimated the distribution of s het using only non-Finnish Europeans (NFE) in Supplementary Figure 10 . We found high concordance between the overall distribution generated using all ExAC samples and NFE-specific estimates. We also separately removed Finnish individuals from the estimation of the distribution of selection coefficients and found very high concordance between estimates made using all ExAC samples and ExAC without Finnish individuals (Supplementary Fig. 11 ). These analyses demonstrate that the model is robust to concerns about recent demographic history in Finnish individuals, supporting the validity of the deterministic approximation. We cannot completely rule out the possibility that other included populations may have issues related to complexities of their recent demographic history.
Inference of s het on individual genes. From the inferred distributionŝˆ;
, a a b P s t t het ( ) in each tercile t of the mutation rate U, we construct a per-gene estimator of s het for genes in the tercile using the posterior probability given n, which mitigates the stochasticity of the observed PTV count:ˆ| Predicted mode of inheritance in clinical exome cases. We trained a naive Bayes classifier to predict the mode of inheritance in a set of solved clinical exome-sequencing cases from Baylor College of Medicine (N = 283 cases) 21 and UCLA 22 (N = 176 cases). Using data from UCLA as the training data set, we were able to cross-predict the mode of inheritance in separately ascertained Baylor cases with classification accuracy of 88.0%, sensitivity of 86.1%, specificity of 90.2%, and an AUC of 0.931. Genes that were related to diagnosis in both clinics (overlapping genes) were removed from the larger Baylor set (Supplementary Fig. 2) .
Using a logistic regression based on the full set of cases from Baylor and UCLA, we generated predictions for all 15,998 genes where there is a s het value (Supplementary Table 4 ).
Mouse knockout comparative analysis. We reviewed mouse knockout enrichments from the full set of mouse knockouts from a neutrally ascertained mouse knockout screen (N = 2,179 genes) generated by the International Mouse Phenotyping Consortium 24 . Genes were classified as viable, sub-viable, or lethal on the basis of the results for the assay.
PubMed gene score and enrichment analysis. We developed a score to estimate the relative importance of each gene in the published medical and scientific literature. First, we connected literature from Entrez, which included both PubMed citations and references to Entrez genes. We assigned a weight to each article referencing a gene of 1/a i , where a i was the number of genes referred to by article i. For example, an article referring to four genes would receive a weight of 1/4. Finally, we assigned each gene a score which was the sum of the weighted article scores. These scores ranged from 4,672 (for p53) to 0.0001. Next, we focused on genes that are estimated to be under very strong selection but that lack functional or clinical annotations. In the top decile of s het values, we separated the top 250 and bottom 250 genes by PubMed score. We then annotated each of these with unbiased genome-wide assays, including the number of protein-protein interactions (as determined by a genome-wide mass spectrometry assay) 50 , whether each gene is determined to be cell-essential in genome-wide CRISPR and gene trap assays 3 , and whether there is a mouse knockout in the neutrally ascertained orthologous nonviable mouse knockout 51 . To limit the number of genes with incorrect s het estimates in this set of 500 genes, we pre-filtered any genes with only a single exon, as they may be enriched for recent pseudogenes, and also removed any olfactory, mucin, and zinc-finger proteins. Genes are also ordered by a heuristic score based on each of the forms of functional evidence in the analysis. (7) (7) 
